Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robot dog brings joy to kids battling blood cancer

NCT ID NCT07607379

Symptom relief Sponsor: Koç University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a robotic dog named AIBO can improve emotional well-being and quality of life in children aged 8-15 with blood cancers who are undergoing a stem cell transplant. The children will interact with AIBO while isolated in the hospital for about 30 days. Researchers will measure changes in mood, emotional health, and overall quality of life using standard questionnaires.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
AIBO robotic dog
What this could lead to
If it works, this could offer a safe, non-drug way to reduce anxiety and loneliness in hospitalized children with cancer.
What could go wrong
This is a very small, early-stage study with only 28 participants. The robotic dog is not a treatment for the cancer itself, and results may not apply to all children.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 28 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

8 to 15 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pediatric patients aged 8-15 years * Diagnosed with a hematological malignancy and undergoing hematopoietic stem cell transplantation * Hospitalized in a protective isolation room during the post-transplant inpatient period * Expected to remain hospitalized under isolation for approximately 30 days post-transplant * Able to understand and respond to Turkish-language self-report questionnaires * Clinically stable and deemed eligible for participation by the treating clinical team * Able to interact with the robotic dog at a basic functional level Exclusion Criteria: * Severe cognitive impairment or neurodevelopmental conditions preventing meaningful interaction or self-report * Acute neurological conditions, delirium, or severe psychiatric crisis (e.g., acute agitation, suicidal ideation) * Requirement for intensive care, invasive ventilation, or a clinically unstable condition * Severe visual, hearing, or motor impairments that prevent interaction with the robotic dog * Additional infection control restrictions prevent the placement or use of the robotic dog in the isolation room * Anticipated early discharge, transfer, or inability to complete follow-up assessments * Severe fear, intolerance, or refusal to interact with robotic or electronic devices

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Emotional well-being are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hematopoietic and lymphoid system neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Emotional well-being Pediatric oncology Quality of life

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.